Publicacions en col·laboració amb investigadors/es de Hannover Medical School (29)

2024

  1. Circulating long noncoding RNA PDE4DIPP6: A novel biomarker for improving the clinical management of non-ST-segment elevation myocardial infarction

    Clinica Chimica Acta, Vol. 561

  2. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

2023

  1. Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  2. Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

    Journal of Translational Medicine, Vol. 21, Núm. 1

2022

  1. Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department

    Clinical Biochemistry, Vol. 99, pp. 9-16

2021

  1. Author Correction: c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis (Nature Metabolism, (2020), 2, 11, (1350-1367), 10.1038/s42255-020-00306-2)

    Nature Metabolism

  2. Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

  3. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 6, pp. 653-660

  4. Going the Long Noncoding RNA Way Toward Cardiac Regeneration: Mapping Candidate Long Noncoding RNA Controllers of Regeneration

    Canadian Journal of Cardiology

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  6. MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

    Theranostics, Vol. 10, Núm. 19, pp. 8665-8676

  2. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker

    FASEB Journal, Vol. 34, Núm. 3, pp. 4403-4414

  3. c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis

    Nature Metabolism, Vol. 2, Núm. 11, pp. 1350-1367

2019

  1. Circulating miRNAs as mediators in cell-to-cell communication

    Epigenomics

  2. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine?

    European Heart Journal, Vol. 40, Núm. 20, pp. 1643-1650

  3. Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

    Scientific Reports, Vol. 8, Núm. 1

  2. Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: Chances and hurdles

    European Heart Journal

  3. Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity

    Scientific Reports, Vol. 8, Núm. 1